Özlem Aydın

Özlem Aydın

Auto-generated profile, based on publicly available information

Özlem Aydın

Istanbul Medeniyet Univ, Goztepe Training & Res Hosp, Clin Infect Dis & Clin Microbiol, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2020 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
OAOzlem Aydın
Ozlem Aydın
PEPinar Ergen
Pinar Ergen
BÖBurak Özturan
Burak Özturan
KOKorhan Ozkan
Korhan Ozkan
FAFerhat Arslan
Ferhat Arslan
HVHaluk Vahaboglu
Haluk Vahaboglu

26 April 2022 in Journal of Chemotherapy
Verified
Journal Article
Closed access
PEPınar Ergen
Pınar Ergen
MKM. Esra Koçoğlu
M. Esra Koçoğlu
MNMüge Nural
Müge Nural
MKMert Ahmet Kuşkucu
Mert Ahmet Kuşkucu
ÖAÖzlem Aydin
Özlem Aydin
HVHaluk Vahaboglu
Haluk Vahaboglu
We analysed a carbapenem-resistant Klebsiella pneumoniae (CRKP) outbreak in the coronavirus disease (COVID) ICU. We retrospectively collected data from ICU records. We identified 25 cases between 12 November 2020 and 19 December 2020, and compared them to 42 controls present in the ICU during the same period. The presence of a femoral haemodialysis catheter was strongly associated with invasive CRKP infections (cases, 9 [36%]; controls, 0 [0%]; odds ratio [OR] 95% confidence intervals [CIs], 21 (5; 89)). We found a significant association between old age and CRKP infection with adverse outcomes. Sequence analysis revealed three distinct carbapenemase genes: blaNDM-1, blaOXA-48 and blaKPC-2. We launched rectal swab sampling upon admission to the ICU, cohorted colonized patients and cases and conducted an intensive training programme for newly employed staff. This study revealed that the emergence and dissemination of CRKP in COVID ICUs were associated with increased adverse outcomes. The presence of a femoral haemodialysis catheter was a significant risk factor for CRKP infections.

28 October 2022 in African Health Sciences
Verified
Journal Article
Open access
PDF file
PEPınar Ergen
Pınar Ergen
BBBEGUM BEKTAS
BEGUM BEKTAS
ÖAÖzlem Aydın
Özlem Aydın
HKHavva Keskin
Havva Keskin
AÜAyşe Canan Üçışık
Ayşe Canan Üçışık
YCYasemin Cag
Yasemin Cag
Background: People living with HIV need to use antiretroviral therapy throughout their lives. Objectives: Studies on the efficacy and safety of dual therapy are limited in Turkey. We sought to evaluate the treatment efficacy and side effects among patients who were given a combination of dolutegravir (DTG) and lamivudine (3TC) as a maintenance therapy. Methods: This retrospective, single-centre study included individuals with viral suppression who were older than 18 years of age, living with HIV, switched from a combination antiretroviral therapy regimen to DTG-3TC dual therapy, and followed up for at least 6 months. Results: The study included 63 patients living with HIV. The median age was 42 years (interquartile range (IQR): 36-51 years). The median follow-up under the DTG-3TC regimen was 10.4 months (7.1-16.0 months). In the course of dual therapy, no patients developed any serious adverse effects that would necessitate a therapy switch, but virological blips were seen in two patients. Two patients lost their lives, with one dying from suicide and one dying from respiratory failure associated with the underlying chronic obstructive pulmonary disease. Conclusion: The DTG-3TC dual-therapy regimen is a promising and effective therapy that can be used as a treatment of choice for eligible patients. Keywords: Dolutegravir; lamivudine; dual; antiretroviral therapy; efficacy.

23 December 2022 in African Health Sciences
Verified
Journal Article
Open access
PDF file
ÖAÖzlem Aydın
Özlem Aydın
HAHandan Ankaralı
Handan Ankaralı
PEPınar Ergen
Pınar Ergen
NBNaciye Betül Baysal
Naciye Betül Baysal
YÇYasemin Çağ
Yasemin Çağ
Background: Low bone mineral density (BMD) is one of the comorbidities that develop in people living with HIV (PLWHIV). Objective: This study was conducted to review the frequency and risk factors of reduced BMD according to age in HIV-infected patients in Turkey. Material and Method: This retrospective cohort study included HIV-infected patients aged 18-50. Bone density was analysed using dual-energy X-ray absorptiometry (DXA) according to the Z-score in three different regions including the lumbar, total-hip and femoral-neck. Results: The study included 224 PLWHIV with a mean age of 35.84-7.54, and 59.8% were ART naive. Of the patients, 40.6% had lower BMD than expected at least in one of the three examined regions including the lumbar, total hip and femoral neck. The low BMD ratios were found respectively as 11.6%, 11.6% and 28.6% in the femoral neck, total hip and lumbar regions. According to the logistic regression model, a high body mass index (p=0.003) and HIV-RNA level of ≥100.000IU/ml during the diagnosis in the ART-naive group (p=0.008) were associated with reduced bone demineralization. The low BMD frequency was high in the group that received ART for <24 months (p=0.001). Conclusion: Performing bone demineralization screening in the naive and young patient group, independently from ART status prior to making the diagnosis of HIV is important for organizing the bone health improvement methods. Keywords: HIV infection; bone density; antiretroviral therapy.

1 January 2022 in Eurasian Journal of Medical Investigation
Verified
Journal Article
Closed access
OAOzlem Aydin
Ozlem Aydin
YCYasemin Cag
Yasemin Cag
PEPinar Ergen
Pinar Ergen
FKFatma Yilmaz Karadag
Fatma Yilmaz Karadag
HAHandan Ankarali
Handan Ankarali
Ejmi Eurasian Journal of Medical Investigation

13 January 2023 in World Journal of Surgery
Verified
Journal Article
Open access
PDF file
OAOzlem Aydın
Ozlem Aydın
PEPınar Ergen
Pınar Ergen
HVHaluk Vahaboglu
Haluk Vahaboglu
Background: Screening with SARS‐CoV‐2 PCR tests is recommended for all patients undergoing surgery under general anesthesia, and elective surgery is deferred for positive patients. This study evaluated the outcomes of asymptomatic PCR‐positive patients who underwent general anesthesia and surgery.Methods: Patient data were collected from the hospital records of patients who underwent surgery between January 2021 and May 2022. Asymptomatic patients with a positive PCR test between 7 days before and 5 days after surgery were compared with controls. The cases were propensity score‐matched with a 1:2 ratio to the controls. All‐cause in‐hospital mortality was the primary outcome of the study.Results: A total of 217 asymptomatic PCR‐positive patients were matched to 434 controls. In multivariate analysis, PCR‐positive test results were not associated with mortality (log(OR) (95%CIs), p; 0.86 (− 0.13, 1.9), 0.09). Age and ASA score (>3) were the most significant risk factors associated with mortality.Conclusion: This study found that surgery among asymptomatic PCR‐positive patients was not associated with increased mortality.